Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Article English OPEN
Schmidt, Heinrich; Giese, Renate; Enders, Angelika; Kern, W.; Hallschmid, M.;

Background: The 22q13 deletion syndrome (Phelan– McDermid syndrome) is characterised by a global developmental delay, absent or delayed speech, generalised hypotonia, autistic behaviour and characteristic phenotypic features. Intranasal insulin has been show... View more
Share - Bookmark